KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $11.1 billion.

  • Johnson & Johnson's Operating Expenses fell 596.96% to $11.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $38.6 billion, marking a year-over-year decrease of 437.83%. This contributed to the annual value of $38.6 billion for FY2025, which is 437.83% down from last year.
  • Per Johnson & Johnson's latest filing, its Operating Expenses stood at $11.1 billion for Q4 2025, which was down 596.96% from $9.7 billion recorded in Q3 2025.
  • Johnson & Johnson's Operating Expenses' 5-year high stood at $11.8 billion during Q4 2024, with a 5-year trough of $7.0 billion in Q1 2023.
  • Its 5-year average for Operating Expenses is $9.5 billion, with a median of $9.5 billion in 2022.
  • Examining YoY changes over the last 5 years, Johnson & Johnson's Operating Expenses showed a top increase of 4805.38% in 2023 and a maximum decrease of 1033.79% in 2023.
  • Over the past 5 years, Johnson & Johnson's Operating Expenses (Quarter) stood at $9.5 billion in 2021, then fell by 10.09% to $8.5 billion in 2022, then increased by 21.36% to $10.3 billion in 2023, then increased by 13.99% to $11.8 billion in 2024, then dropped by 5.97% to $11.1 billion in 2025.
  • Its Operating Expenses stands at $11.1 billion for Q4 2025, versus $9.7 billion for Q3 2025 and $9.5 billion for Q2 2025.